Alaunos Therapeutics Inc
TCRT2.835USD
+0.095+3.47%
取引時間 （ET）15分遅れの株価
4.54M時価総額
損失額直近12ヶ月PER
詳細情報 Alaunos Therapeutics Inc 企業名
Alaunos Therapeutics, Inc. is a clinical-stage oncology-focused cell therapy company. The Company is focused on exploring strategic alternatives, including, but not limited to, an acquisition, merger, reverse merger, sale of assets, strategic partnerships, capital raises or other transactions. Separately, the Company is evaluating several potential in-licensing opportunities in obesity, oncology and virology.
企業情報
企業コードTCRT
会社名Alaunos Therapeutics Inc
上場日Aug 20, 2004
最高経営責任者「CEO」Mr. Holger Weis, CPA
従業員数1
証券種類Ordinary Share
決算期末Aug 20
本社所在地2617 Bissonnet St
都市HOUSTON
証券取引所NASDAQ Capital Market Consolidated
国United States of America
郵便番号77005
電話番号13463554099
ウェブサイトhttps://alaunos.com/
企業コードTCRT
上場日Aug 20, 2004
最高経営責任者「CEO」Mr. Holger Weis, CPA
役員一覧
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Holger Weis, CPA
Mr. Holger Weis, CPA
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
1.21K
--
Mr. Robert W. Postma
Mr. Robert W. Postma
Independent Director
Independent Director
--
--
Mr. Jaime W. Vieser
Mr. Jaime W. Vieser
Independent Director
Independent Director
--
--
Mr. Ferdinand Groenewald
Mr. Ferdinand Groenewald
Vice President - Finance
Vice President - Finance
--
--
Mr. Michael Jerman
Mr. Michael Jerman
Director
Director
--
--
Ms. Melinda Lackey, J.D.
Ms. Melinda Lackey, J.D.
Legal and Administrative Officer, Corporate Secretary
Legal and Administrative Officer, Corporate Secretary
--
--
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Holger Weis, CPA
Mr. Holger Weis, CPA
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
1.21K
--
Mr. Robert W. Postma
Mr. Robert W. Postma
Independent Director
Independent Director
--
--
Mr. Jaime W. Vieser
Mr. Jaime W. Vieser
Independent Director
Independent Director
--
--
Mr. Ferdinand Groenewald
Mr. Ferdinand Groenewald
Vice President - Finance
Vice President - Finance
--
--
Mr. Michael Jerman
Mr. Michael Jerman
Director
Director
--
--
Ms. Melinda Lackey, J.D.
Ms. Melinda Lackey, J.D.
Legal and Administrative Officer, Corporate Secretary
Legal and Administrative Officer, Corporate Secretary
--
--
収益内訳
データなし
データなし
事業別
地域別
データなし
株主
更新時刻: Fri, Jul 4
更新時刻: Fri, Jul 4
株主統計
種類
株主統計
株主統計
比率
PMGC Capital LLC
4.22%
Watermill Asset Management
1.69%
Vieser (Jaime W.)
1.69%
Postma (Robert W.)
1.68%
BlackRock Institutional Trust Company, N.A.
1.08%
Other
89.65%
株主統計
株主統計
比率
PMGC Capital LLC
4.22%
Watermill Asset Management
1.69%
Vieser (Jaime W.)
1.69%
Postma (Robert W.)
1.68%
BlackRock Institutional Trust Company, N.A.
1.08%
Other
89.65%
種類
株主統計
比率
Investment Advisor
4.26%
Corporation
4.22%
Individual Investor
3.65%
Investment Advisor/Hedge Fund
0.80%
Hedge Fund
0.08%
Bank and Trust
0.07%
Research Firm
0.06%
Other
86.86%
機関投資家保有株
更新時刻: Tue, Jul 1
更新時刻: Tue, Jul 1
報告期間
機関投資家数
保有株式数
比率
変動額
2025Q2
153
252.48K
13.08%
-146.72K
2025Q1
169
296.91K
17.46%
-90.28K
2024Q4
182
298.15K
18.62%
-116.62K
2024Q3
208
422.39K
26.38%
-38.04K
2024Q2
224
471.36K
29.44%
+11.94K
2024Q1
281
305.54K
19.08%
-201.69K
2023Q4
302
346.05K
21.58%
-260.76K
2023Q3
324
525.07K
33.28%
-179.72K
2023Q2
339
599.70K
37.93%
-192.22K
2023Q1
357
606.92K
38.76%
-233.79K
詳細を見る
株主動向
会社名
保有株式数
比率
変動額
変動率
日付
PMGC Capital LLC
83.50K
4.22%
+83.50K
--
May 12, 2025
Watermill Asset Management
33.33K
1.69%
+33.33K
--
Jun 24, 2025
Vieser (Jaime W.)
29.93K
1.83%
+17.46K
+140.07%
Apr 30, 2025
Postma (Robert W.)
29.10K
1.47%
-33.34K
-53.40%
Jun 24, 2025
BlackRock Institutional Trust Company, N.A.
21.35K
1.08%
--
--
Mar 31, 2025
The Vanguard Group, Inc.
20.97K
1.06%
--
--
Mar 31, 2025
Geode Capital Management, L.L.C.
15.61K
0.79%
+394.00
+2.59%
Mar 31, 2025
UBS Financial Services, Inc.
6.63K
0.34%
--
--
Mar 31, 2025
Hogue (Dale Curtis Jr.)
4.44K
0.22%
+442.00
+11.05%
Apr 30, 2025
Tower Research Capital LLC
1.68K
0.08%
+527.00
+45.87%
Mar 31, 2025
詳細を見る
関連ETF
更新時刻: Sat, Aug 2
更新時刻: Sat, Aug 2
銘柄名
比率
iShares Core S&P Total U.S. Stock Market ETF
0%
iShares Biotechnology ETF
0%
Invesco Nasdaq Biotechnology ETF
0%
ProShares Ultra Nasdaq Biotechnology
0%
iShares Core S&P Total U.S. Stock Market ETF
比率0%
iShares Biotechnology ETF
比率0%
Invesco Nasdaq Biotechnology ETF
比率0%
ProShares Ultra Nasdaq Biotechnology
比率0%
配当金
過去5年間の配当金総支払額は
0.00
米ドルである。
日付
配当金
権利確定日
支払日
配当落ち日
データなし
株式分割
日付
種類
比率
Jul 16, 2024
Merger
10<1
Jul 16, 2024
Merger
10<1
Jul 16, 2024
Merger
10<1
Jul 16, 2024
Merger
10<1
Jan 29, 2024
Merger
15<1
Jan 29, 2024
Merger
15<1
日付
種類
比率
Jul 16, 2024
Merger
10<1
Jul 16, 2024
Merger
10<1
Jul 16, 2024
Merger
10<1
Jul 16, 2024
Merger
10<1
Jan 29, 2024
Merger
15<1
Jan 29, 2024
Merger
15<1
Jan 29, 2024
Merger
15<1
Jan 29, 2024
Merger
15<1
